We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+5.29%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$39.5B
AUM Growth
+$3.17B
Cap. Flow
+$1.77B
Cap. Flow %
4.5%
Top 10 Hldgs %
14.6%
Holding
2,920
New
47
Increased
1,798
Reduced
994
Closed
66

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$26.1M
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$22M
3
AAPL icon
Apple
AAPL
+$20.6M
4
MSFT icon
Microsoft
MSFT
+$18.3M
5
T icon
AT&T
T
+$15.4M

Sector Composition

Rank Sector Weight
1 Financials 16.57%
2 Technology 14.46%
3 Healthcare 12.77%
4 Industrials 10.91%
5 Consumer Discretionary 9.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVEE
2576
DELISTED
NV5 Global
NVEE
$250K ﹤0.01%
29,952
+3,276
+12% +$26.9K
SGRY icon
2577
Surgery Partners
SGRY
$2.01B
$250K ﹤0.01%
15,778
-4,074
-21% -$67.7K
RDNT icon
2578
RadNet
RDNT
$5.02B
$249K ﹤0.01%
38,563
+2,713
+8% +$18.3K
FNM
2579
DELISTED
FANNIE MAE
FNM
$248K ﹤0.01%
63,500
CLFD icon
2580
Clearfield
CLFD
$411M
$247K ﹤0.01%
11,946
+859
+8% +$16.3K
FC icon
2581
Franklin Covey
FC
$242M
$247K ﹤0.01%
12,280
-3,802
-24% -$74.2K
PFSI icon
2582
PennyMac Financial
PFSI
$3.92B
$247K ﹤0.01%
14,863
-329
-2% -$5.6K
PETX
2583
DELISTED
Aratana Therapeutics, Inc.
PETX
$247K ﹤0.01%
34,387
-62
-0.2% -$501
FRE
2584
DELISTED
FREDDIE MAC D/B/A VOTING
FRE
$247K ﹤0.01%
66,008
CIO
2585
DELISTED
City Office REIT
CIO
$246K ﹤0.01%
18,715
+1,631
+10% +$20.4K
PLUG icon
2586
Plug Power
PLUG
$2.87B
$246K ﹤0.01%
205,163
+24,468
+14% +$35.9K
GBT
2587
DELISTED
Global Blood Therapeutics, Inc.
GBT
$246K ﹤0.01%
17,042
+4,156
+32% +$73K
RPD icon
2588
Rapid7
RPD
$645M
$245K ﹤0.01%
20,097
+3,920
+24% +$53.1K
PRMW
2589
DELISTED
Primo Water Corporation
PRMW
$245K ﹤0.01%
19,973
+289
+1% +$3.71K
ODC icon
2590
Oil-Dri
ODC
$1.44B
$243K ﹤0.01%
12,714
-4
-0% -$74
SGA icon
2591
Saga Communications
SGA
$57M
$243K ﹤0.01%
4,832
-45
-0.9% -$2.12K
ADSW
2592
DELISTED
Advanced Disposal Services Inc
ADSW
$243K ﹤0.01%
+10,930
New +$220K
CLMS
2593
DELISTED
Calamos Asset Management, Inc.
CLMS
$243K ﹤0.01%
28,370
-7,607
-21% -$52.8K
GLUU
2594
DELISTED
Glu Mobile Inc.
GLUU
$242K ﹤0.01%
124,894
-27,507
-18% -$57.7K
BREW
2595
DELISTED
Craft Brew Alliance, Inc.
BREW
$242K ﹤0.01%
14,294
+957
+7% +$15.8K
ACAS
2596
DELISTED
American Capital Ltd
ACAS
$242K ﹤0.01%
13,500
-13,600
-50% -$234K
LCUT icon
2597
Lifetime Brands
LCUT
$191M
$241K ﹤0.01%
13,575
+247
+2% +$3.9K
GBL
2598
DELISTED
GAMCO Investors, Inc.
GBL
$241K ﹤0.01%
7,806
+88
+1% +$2.67K
CVLG icon
2599
Covenant Logistics
CVLG
$894M
$240K ﹤0.01%
24,852
-1,182
-5% -$11.1K
SMRT
2600
DELISTED
Stein Mart Inc
SMRT
$239K ﹤0.01%
43,673
+3,014
+7% +$17.5K

Similar funds

RhumbLine Advisers's Q4 2016 Portfolio in Review

As of Q4 2016, RhumbLine Advisers held 2,920 positions worth $39.5B, up 8.7% from $36.3B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

RhumbLine Advisers deployed $1.77B of net new capital in Q4 2016, opening 47 new positions and adding to 1,798 existing holdings. Its largest new stake was Howmet Aerospace: 952,104 shares worth $13.5M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Procter & Gamble, an estimated $21.2M trimmed.

  • RhumbLine Advisers's largest Q4 2016 buy was Howmet Aerospace: 952,104 shares worth $13.5M.
  • RhumbLine Advisers added most to ExxonMobil in Q4 2016, an estimated $26.1M increase.
  • RhumbLine Advisers's biggest Q4 2016 reduction was Procter & Gamble, cutting an estimated $21.2M.
  • RhumbLine Advisers fully exited LinkedIn Corporation in Q4 2016, selling an estimated $24.4M.
  • RhumbLine Advisers's ten largest holdings make up 15% of its $39.5B portfolio in Q4 2016.
  • RhumbLine Advisers opened 47 new positions and closed 66 in Q4 2016.
  • RhumbLine Advisers's portfolio value rose 8.7% quarter-over-quarter to $39.5B.

Based on RhumbLine Advisers's 13F filing for Q4 2016, filed 27 Jan 2017.